Bicara Therapeutics, Inc. (BCAX)
21.17
+0.96
(+4.75%)
USD |
NASDAQ |
Jun 11, 13:43
Bicara Therapeutics Price to Book Value : 2.700 for June 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 2.578 |
| June 09, 2026 | 2.622 |
| June 08, 2026 | 2.563 |
| June 05, 2026 | 2.551 |
| June 04, 2026 | 2.603 |
| June 03, 2026 | 2.551 |
| June 02, 2026 | 2.505 |
| June 01, 2026 | 2.630 |
| May 29, 2026 | 2.774 |
| May 28, 2026 | 2.774 |
| May 27, 2026 | 2.759 |
| May 26, 2026 | 2.810 |
| May 22, 2026 | 2.772 |
| May 21, 2026 | 2.664 |
| May 20, 2026 | 2.612 |
| May 19, 2026 | 2.561 |
| May 18, 2026 | 2.466 |
| May 15, 2026 | 2.586 |
| May 14, 2026 | 2.640 |
| May 13, 2026 | 2.683 |
| May 12, 2026 | 2.861 |
| May 11, 2026 | 2.930 |
| May 08, 2026 | 2.887 |
| May 07, 2026 | 2.952 |
| May 06, 2026 | 3.04 |
| Date | Value |
|---|---|
| May 05, 2026 | 2.961 |
| May 04, 2026 | 2.900 |
| May 01, 2026 | 2.766 |
| April 30, 2026 | 2.754 |
| April 29, 2026 | 2.716 |
| April 28, 2026 | 2.798 |
| April 27, 2026 | 2.869 |
| April 24, 2026 | 2.891 |
| April 23, 2026 | 2.915 |
| April 22, 2026 | 3.016 |
| April 21, 2026 | 2.950 |
| April 20, 2026 | 2.996 |
| April 17, 2026 | 3.065 |
| April 16, 2026 | 3.054 |
| April 15, 2026 | 3.028 |
| April 14, 2026 | 2.931 |
| April 13, 2026 | 2.824 |
| April 10, 2026 | 2.694 |
| April 09, 2026 | 2.803 |
| April 08, 2026 | 2.756 |
| April 07, 2026 | 2.715 |
| April 06, 2026 | 2.659 |
| April 02, 2026 | 2.738 |
| April 01, 2026 | 2.614 |
| March 31, 2026 | 2.537 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
Price to Book Value Related Metrics
| PEG Ratio | -0.1205 |
| Price | 21.17 |
| Earnings Yield | -13.09% |
| Market Cap | 1.388B |
| PEGY Ratio | -0.1205 |